🇮🇱 Augtyro in Israel

Augtyro (REPOTRECTINIB) regulatory status in Israel.

Marketing authorisation

MOH

  • Status: likely_approved

Augtyro in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Israel

Frequently asked questions

Is Augtyro approved in Israel?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for Augtyro in Israel?

Bristol is the originator. The local marketing authorisation holder may differ — check the official source linked above.